Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Economic evaluation of Medically Assisted Reproduction: An educational overview of methods and applications for healthcare professionals.
Luyten J, Connolly MP, Verbeke E, Buhler K, Scotland G, Lispi M, Revelli A, Borget I, Cedrin-Durnerin I, D'Hooghe T. Luyten J, et al. Among authors: borget i. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):217-228. doi: 10.1016/j.bpobgyn.2022.01.008. Epub 2022 Feb 2. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 35219590 Free article. Review.
Attentes méthodologiques pour la démonstration de l’efficacité des produits de santé par les études observationnelles.
Cucherat M, Demarcq O, Chassany O, Le Jeunne C, Borget I, Collignon C, Diebolt V, Feuilly M, Fiquet B, Leyrat C, Naudet F, Porcher R, Schmidely N, Simon T, Roustit M. Cucherat M, et al. Among authors: borget i. Therapie. 2024 Oct 22:S0040-5957(24)00168-9. doi: 10.1016/j.therap.2024.10.052. Online ahead of print. Therapie. 2024. PMID: 39537531 Free article. French. No abstract available.
Real-world data and evidence in health technology assessment: When are they complementary, substitutes, or the only sources of data compared to clinical trials?
de Pouvourville G, Armoiry X, Lavorel A, Bilbault P, Maugendre P, Bensimon L, Beziz D, Blin P, Borget I, Bouée S, Collignon C, Dervaux B, Durand-Zaleski I, Julien M, de Léotoing L, Majed L, Martelli N, Séjourné T, Viprey M. de Pouvourville G, et al. Among authors: borget i. Therapie. 2023 Jan-Feb;78(1):81-94. doi: 10.1016/j.therap.2022.11.001. Epub 2022 Nov 12. Therapie. 2023. PMID: 36464522
[Real-life evaluation of the care pathway of patients eligible for axicabtagene ciloleucel treatment: Analysis of a multicenter retrospective cohort (IMPA-CT study)].
Cartron G, Thieblemont C, Borget I, Rioufol C, Berthet M, Portal C, Baujat C, Alaoui E, Baffert S, Lacroix D, Bories P, Yakoub-Agha I, Houot R. Cartron G, et al. Among authors: borget i. Bull Cancer. 2024 Nov;111(11):1020-1029. doi: 10.1016/j.bulcan.2024.07.010. Epub 2024 Sep 11. Bull Cancer. 2024. PMID: 39266425 French.
152 results